To validate the performance of this signature, we analyzed RNA-seq data from the PUCH cohort26 and three independent external datasets from melanoma patients treated with anti-PD-1 (Riaz1729, Gide1930, Liu1931, Supplementary Table 5). The gene discussed is PDCD1; the disease is melanoma.